Show simple item record

Selective incorporation of iododeoxyuridine into DNA of hepatic metastases versus normal human liver

dc.contributor.authorSpeth, Paul A Jen_US
dc.contributor.authorKinsella, Timothy Jen_US
dc.contributor.authorChang, Alfred Een_US
dc.contributor.authorKlecker, Raymond Wen_US
dc.contributor.authorBelanger, Karlen_US
dc.contributor.authorCollins, Jerry Men_US
dc.date.accessioned2015-01-07T15:23:27Z
dc.date.available2015-01-07T15:23:27Z
dc.date.issued1988-10en_US
dc.identifier.citationSpeth, Paul A J; Kinsella, Timothy J; Chang, Alfred E; Klecker, Raymond W; Belanger, Karl; Collins, Jerry M (1988). "Selective incorporation of iododeoxyuridine into DNA of hepatic metastases versus normal human liver." Clinical Pharmacology & Therapeutics 44(4): 369-375.en_US
dc.identifier.issn0009-9236en_US
dc.identifier.issn1532-6535en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/109868
dc.publisherWiley Periodicals, Inc.en_US
dc.titleSelective incorporation of iododeoxyuridine into DNA of hepatic metastases versus normal human liveren_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/109868/1/cptclpt1988166.pdf
dc.identifier.doi10.1038/clpt.1988.166en_US
dc.identifier.sourceClinical Pharmacology & Therapeuticsen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.